பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் இன்க் Today - Breaking & Trending Today

Aleor Dermaceuticals receives USFDA tentative approval for Efinaconazole Topical Solution

Alembic Pharmaceuticals (Alembic) today announced that its joint venture Aleor Dermaceuticals (Aleor) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Efinaconazole Topical Solution, 10%.
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jublia Topical Solution, 10%, of Bausch Health Americas, Inc. (Bausch).
Efinaconazole Topical Solution, 10% is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) ....

Aleor Dermaceuticals , Alembic Pharmaceuticals , Bausch Health Americas Inc , Us Food Drug Administration , Drug Administration , Abbreviated New Drug Application , Efinaconazole Topical Solution , Jublia Topical Solution , Bausch Health Americas , Topical Solution , Capital Market , அலெவ்ர் தோல் , அலெம்பிக் மருந்துகள் , பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் இன்க் , பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் , மேற்பூச்சு தீர்வு , மூலதனம் சந்தை ,

Aleor Dermaceuticals receives USFDA Tentative Approval for Efinaconazole Topical Solution, 10%

Aleor Dermaceuticals receives USFDA Tentative Approval for Efinaconazole Topical Solution, 10%
Posted On:
2021-04-07 22:47:15
(Time Zone: Arizona, USA)
Alembic Pharmaceuticals Limited (Alembic) today announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Efinaconazole Topical Solution, 10%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jublia Topical Solution, 10%, of Bausch Health Americas, Inc. (Bausch). Efinaconazole Topical Solution, 10% is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Efinaconazole Topical Solution, 10% has an estimated market size of US$ 233 million for twelve months ending December 2020 according to IQVIA. Aleor has settled the case with Bausch Health and. will ....

United States , Aleor Dermaceuticals , Alembic Pharmaceuticals Limited , Bausch Health Americas Inc , Aleor Dermaceuticals Limited , Us Food Drug Administration , Bausch Health , Efinaconazole Topical Solution , Time Zone , Pharmaceuticals Limited , Drug Administration , Abbreviated New Drug Application , Jublia Topical Solution , Bausch Health Americas , Topical Solution , ஒன்றுபட்டது மாநிலங்களில் , அலெவ்ர் தோல் , அலெம்பிக் மருந்துகள் வரையறுக்கப்பட்டவை , பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் இன்க் , அலெவ்ர் தோல் வரையறுக்கப்பட்டவை , பாஷ் ஆரோக்கியம் , நேரம் ஸோந் , மருந்துகள் வரையறுக்கப்பட்டவை , பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் , மேற்பூச்சு தீர்வு ,

Sensex, Nifty scale record high

Read more about Sensex, Nifty scale record high on Business Standard. Key benchmark indices are trading firm in early trade on buying demand in index pivotals. At 9:25 IST, the barometer index, the S&P BSE Sensex, was up 366.54 points or 0.78% at 47,340.08. The Nifty 50 index was up 106.30 points or 0.77% at ....

United States , New Zealand , United Kingdom , Donald Trump , Zydus Cadila , Boris Johnson , Cyber City Developers , Bausch Health Americas Inc , European Commission , Drug Administration , Horizon Center , National Bureau Of Statistics , Reliance Industries , Efinaconazole Topical Solution , United States Food , Jublia Topical Solution , Bausch Health Americas , City Developers , Securities Purchase Agreement , Fairleaf Real Estate , Zone Horizon , National Bureau , Capital Market , Nifty 50 , Bse Sensex , Stock Exchanges ,

Lupin gets tentative approval for Efinaconazole Topical Solution

Lupin announced that it has received tentative approval for its Efinaconazole Topical Solution, 10%, from the United States Food and Drug Administration, to market a generic equivalent of Jublia Topical Solution, 10%, of Bausch Health Americas, Inc.
Efinaconazole Topical Solution, 10%, is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes. Efinaconazole Topical Solution, 10%, (RLD: Jublia) had estimated annual sales of $222.9 million in the U.S. (IQVIA MAT September 2020).
The announcement was made after market hours on Thursday, 24 December 2020. Shares of Lupin rose 1.37% to settle at Rs 976.15 on Thursday.
The stock hit a 52-week high of Rs 1121.85 on 18 September 2020. The stock hit a 52-week low of Rs 505 on 13 March 2020. ....

South Africa , United States , Asia Pacific , Bausch Health Americas Inc , Drug Administration , Efinaconazole Topical Solution , United States Food , Jublia Topical Solution , Bausch Health Americas , Topical Solution , Latin America , Capital Market , Health Sciences , Life Sciences , Topical Medication , Bausch Health , Wide Range , Innovation Led Transnational Pharmaceutical , Biotechnology Products , ஒன்றுபட்டது மாநிலங்களில் , ஆசியா பெஸிஃபிக் , பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் இன்க் , ஒன்றுபட்டது மாநிலங்களில் உணவு , பாஷ் ஆரோக்கியம் அமெரிக்காக்கள் , மேற்பூச்சு தீர்வு , லத்தீன் அமெரிக்கா ,

RIL, Lupin, DLF in focus

Shares of Reliance Industries (RIL) will be in focus. RIL has entered into definitive agreements to acquire the shares held by IMG Singapore Pte. Ltd in IMG-R, for a cash consideration not exceeding Rs 52.08 crore. Post completion of acquisition, IMG-R will become a wholly-owned subsidiary of the company and will be rebranded by the company. IMG Reliance (IMG-R) is a joint venture between IMG Worldwide LLC (IMG) and RIL. IMG Singapore Pte. Ltd., a wholly owned subsidiary of IMG, holds 50% of the share capital of IMG-R. IMG-R is engaged in the business of creation, management, implementation and commercialisation of sporting, fashion and entertainment events in India. ....

United States , Zydus Cadila , Cyber City Developers , Bausch Health Americas Inc , Horizon Center , Drug Administration , Reliance Industries , Efinaconazole Topical Solution , United States Food , Jublia Topical Solution , Bausch Health Americas , City Developers , Securities Purchase Agreement , Fairleaf Real Estate , Zone Horizon , Capital Market , Bse Sensex , Nifty 50 , Topical Solution , Img Singapore Pte Ltd , Img Worldwide Llc , Solar Power Value Chain , Aluminium Value Chain , Coal India , Dlf Group , ஒன்றுபட்டது மாநிலங்களில் ,